Compare Boston Scientific Corporation (BSX) vs iShares Gold Trust (IAU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs iShares Gold Trust — how do they compare? Boston Scientific Corporation trades at $43.38 (market cap $66.37B), while iShares Gold Trust trades at $76.13. The key difference: iShares Gold Trust is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | IAU | |
|---|---|---|
Market Cap | $66.37B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $108.14 | $101.57 |
52-Week Low | $42.63 | $61.62 |
Enterprise Value | $75.94B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
IAU, the iShares Gold Trust ETF, is trading at $75.25, down 2.6% with a bearish technical outlook. The ETF faces pressure from rising Treasury yields and Federal Reserve policy uncertainty, though recent weaker CPI data provided temporary support. Gold remains a key asset amid geopolitical tensions and central bank accumulation, with the fund offering low-cost exposure to physical gold.
The outlook for IAU is mixed, balancing strong long-term fundamentals against near-term headwinds. Gold's role as a hedge and central bank demand provide support, but Fed policy and dollar strength pose risks. The ETF's structure offers efficient gold access, but price volatility requires careful position sizing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About iShares Gold Trust
IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.
Read more on IAU →
